Mobile Site ›
Normal View

Test ID: EPOR
Erythropoietin Receptor (EPOR) Gene, Exon 8 Sequencing

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

This test is a third-order test and should be ordered when the patient meets the following criteria: diagnosis of lifelong and sustained erythrocytosis, JAK2 V617F is negative, serum erythropoietin levels are decreased to normal, and p50 values are normal.

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

This test does not provide a serum erythropoietin (Epo) level. If Epo testing is desired, see EPO/80173 Erythropoietin (EPO), Serum.

 

This evaluation is recommended for patients presenting with lifelong erythrocytosis, usually with a positive family history of similar symptoms. Polycythemia vera should be excluded prior to testing as it is much more common than hereditary erythrocytosis and can be present even in young patients. A JAK2 V617F or JAK2 exon 12 mutation should not be present. Additionally, p50 testing should be performed and a normal result confirmed before ordering this test. For a complete evaluation including p50 testing, hemoglobin electrophoresis testing, and hereditary erythrocytosis mutation analysis in an algorithmic fashion, order the erythrocytosis evaluation panel (REVP/84160 Erythrocytosis Evaluation).

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Amplification/Sanger Sequence Analysis

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

EPOR Gene, Mutation Analysis, B

Specimen Type Describes the specimen type needed for testing

Whole blood

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

0.5 mL

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
Whole bloodRefrigerated30 days

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Interpretation Provides information to assist in interpretation of the test results

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

 

Method Description Describes how the test is performed and provides a method-specific reference

Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis Mutations.

Performing Laboratory Location The location of the laboratory that performs the test

Rochester

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

81479-Unlisted molecular pathology procedure

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
34645EPOR Gene Sequencing ResultIn Process